Collectively, the decreased expression of cyclin B1 and CDC2 and the increased expression of p53 and p21 contribute to ALS-induced G2/M phase arrest of HT29 cells. The gene discussed is CDKN1A; the disease is amyotrophic lateral sclerosis.